137. Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV) - Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV 67 // PLoS One. - 2011. - Vol.6, №5.
138. Faure, M. Vulvar erosions ans ulcerations / M. Faure // Eurogin 2000: materials 4th International Multidisciplinary Congress (Paris, France, 5-9 April 2000), 2000. - P. 30.
139. Faure, M. Vulvar IGA cicatricial pemphigoid / M. Faure // Eurogin 2000: materials 4th International Multidisciplinary Congress (Paris, France, 5-9 April 2000), 2000. - P. 82.
140. Global cancer statistics, 2002 / D.M. Parkin, F. Bray, J. Ferlay [et al.] // CA Cancer J. Clin. - 2005. - № 55. - P. 74.
141. GLOBOCAN 2008. Estimated cancer Incidence, Mortality, Prevalence and Disability-adjusted life years (DALYs). Worldwide in 2008 [Electronic resource]. - Access mode: http://globocan.iarc.fr.
142. Gray, H.J. Primary management of early stage cervical cancer (IA1-IB) and appropriate of adjuvant therapy / H.J. Gray // J. Natl. Compr. Canc. Netw. - 2008. - Vol.6, № 1. - P. 47-52.
143. Gusberg, S.B. Estrogen and endometrial cancer: an epilogue a la recherchй du temps perdu / S.B. Gusbrrg // Cynecol. Oncol. - 1994. - № 52(1). - P. 3-9.
144. Hakulinen, T. A computer program package for relative survival analysis / T. Hakulinen, K.H. Abeywichkrama // Comput. Program. Biomed. - 1985. - № 19. - P. 197-207.
145. Hakulinen, T. On long-term relative survival rates / T. Hakulinen // J. Chtonic Dis. - 1977. - № 30. - P. 431-443.
146. Hollwith, B. Vulvar and Vaginal intraepithelial high-grade-neoplasia in HIV-positive women with multilocular HPV-infection / B. Hollwith // Eurogin 2000: materials 4th International Multidisciplinary Congress (Paris, France, 5-9 April 2000), 2000. - P. 68.
147. Human Papillomavirus and Related Cancer [Electronic resource]. - 2010, Jun 22. - Access mode: http://www.who.int/hpvcentre.
148. Katki, H.A. How might HPV testing be integrated into cervical screening? / H.A. Katki, N. Wentzensen // Lancet Oncol. - 2012. - Vol. 13, №1. - P. 8-10.
149. Key, T.J. The dose-effect relationship between `unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk / T.J. Key, M.C. Pike // Br. J. Cancer. - 1988. - № 57. - P. 205-212.
150. Lawrence, W.D. Histopathology of Ovarian Neoplasia / W.D. Lawrence, P. Papas; ed by H.M. Shingleton, W.C. Fowler, J.J. Jordan [et al.] // Gynecologic Oncology: Current Diagnosis and Treatment. - London, 1996. - P. 174.
151. Lui, F.S. Molecular carcinogenesis of endometrial cancer / F.S. Lui // J. Obstet. Gynecol. - Taiwan. - 2007. - Mar № 46(1). - P. 26-32.
152. McGuire, W.P. Current aspects of adjuvant therapy of early stage ovarian cancer / W.P. McGuire // Zentralbl. Gynecol. - 1998. - № 120. - P. 93.
153. Multiple HPV infection in cervical cancer screened by HPV DNA Chip / S.A. Lee, D. Kang, S.S. Seo [et al.] // Cancer Lett. - 2003. - Vol. 198. - P. 187-192.
154. National cancer control programmes. Policies and managerial guidelines / World health organization. - 2-th ed, 2002. - 152 p.
155. Of survival cancer resistration: principles and Methods / D. Parkin, T. Hakulinen, T. Analusis. - Lyon, 1999 (№ 95). - P. 159-176.
156. Parkin, D.M. Death from cervical cancer / D.M. Parkin // Lancet. - 1999. - № 8484. - P. 797.
157. Pathology and genetics of tumours of the breast and female genital organs / ed by F.A. Tavassoli, P. Devilee; World health organization classification of tumours, 2003. - 432 p.
158. Patnick, J. Organisation of cervical screening in the UK / J. Patnick // Eurogin 2000: materials 4th International Multidisciplinary Congress (Paris, France, 5-9 April 2000), 2000. - P. 49.
159. Patnick, J. Screening programmes in the European Union / J. Patnick // Eurogin 2000: materials 4th International Multidisciplinary Congress (Paris, France, 5-9 April 2000), 2000. - P. 11.
160. Peitsaro, P. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique / P. Peitsaro, B. Johansson, S. Syrjanen // J. Clin. Microbiol. - 2002. - Vol. 40. - P. 886-891.
161. Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark / S.K. Kjar, G. Breugelmans, Ch. Munk [et al.] // Int. J. Cancer. - 2008. - № 123. - P. 1864-1870.
162. Pre-and post conization high-risk HPV testing predicts residual recurrent disease in patients treated for cin 2-3 / Y. Alonso, A. Torne, L.M. Puigtuntore [et al.] // Gynecol. Oncol. - 2006. - Vol.103. - P.631-636.
163. Prevalence of single and multiple infection with human papillomaviruses in various grades of cervical neoplasia / D.Y. Chang, R.J. Chen, S.C. Lee [et al.] // J. Med. Microbiol. - 1997. - Vol.46, №1. - P. 54-60.
164. Profile of cervical cancer in England. Incidence mortality and survival // Trent cancer registry. - 2012. - P. 17.
165. Recent cancer survival in Europe: a 2000-2002 period analysis of Eurocare-4 data / A. Verdecchia, S. Francisci, H. Brenner [et al.] // The lancet oncology. - 2007. - Vol. 8, issue 9 September. - P. 784-796.
166. Richards, M. Eurocare-4 studies bring new data on cancer survival / M. Richards // The lancet oncology. - 2007. - Vol. 8, issue 9 September. - P. 752-753.
167. Risk of invasive cervical cancer associated with polymorphic HLA DR/DQ haplotypes / M. Ghaderi, K.L. Wallin, F. Wiklund [et al.] // Int. J. Cancer. - 2002. - Vol.100, №6. - P. 698-701.
168. Safe Criteria for Less Radical Trachelectomy in Patients with Early-Stage Cervical Cancer: A Multicenter Clinicopathologic Study / H.S. Kim, C.H. Choi, S.J. Chang [et al.] // Ann Surg Oncol. - 2011. - Dec 20.
169. SEER Cancer Statistics Review, 1975-2008 [Electronic resource] / N. Howlader, A.M. Noone, M. Krapcho [et al.]; ed by B.K. Edwards // National Cancer Institute. - Bethesda, MD. - Access mode
170. Statistical Methods in cancer research. The analysis of case-control studies / ed by N.E. Breslow, N.E. Day. - Lyon, 1980. - Vol. 1, № 32. - 343 p.
171. Stephen, C.R. Cervical cancer: successes and failures / C.R. Stephen // CA Cancer. J. Clin. - 2001. - Vol. 51, № 2. - P. 89-91.
172. Survay of cancer patients in Europe: the Eurocare-3. Study / ed by F. Berrino [et al.] // Annals of Oncology: Oxford press. - 2003. - Vol. 14, Supplement 5.
173. The development of priority cervical cancer trials: a Gynecologic Cancer InterGroup report / H.C. Kitchener, W. Hoskins, W. Small [et al.] // Int. J. Gynecol. Cancer. - 2010. - Vol. 20, № 6. - P. 1092-1100.
174. The Interaction Between HPV and estrogen Metabolism in Cervical Carcinogenesis / K.J. Auborn, C. Woodworth, Di Paolo [et al.] // Int. Cancer. - 1991. - Vol.49, №.6. - P.867-869.
175. The management of women with apparent early ovarian cancer in the south-west region of England / A. Olaitan, J. Murdoch, J. James [et al.] // J. Obstet. Gynaecol. - 2002. - Vol. 22, № 4. - P. 394-398.
176. Weiderpass, E. Alcoholism and risk for cancer of the cervix uteri, vagina and vulva / E. Weiderpass, W. Ye, R. Tamimi [et al.] // Cancer Epidemiol Biomarkers Prev. - 2001. - Vol. 10, № 8. - P. 899-901.
177. Weiderpass, E. Hormonal risk factors of cancer in humars point of cancer epidemiologist international conference. Hamonal carcinoseneses / E. Weiderpass. - St. Petersburg, 2000. - P. 22-23.
178. zur Hausen, H. Papillomavirus infections a major cause of human cancer / H. zur Hausen // Biochim Biophys Acta. - 1996. - P. 1288.